Aravive Analyst Ratings
Aravive Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/21/2023 | 922.73% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
07/17/2023 | 922.73% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
07/10/2023 | 922.73% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
07/03/2023 | 922.73% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight |
06/05/2023 | 581.82% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
06/05/2023 | 468.18% | EF Hutton | → $10 | Reiterates | Buy → Buy |
05/26/2023 | 468.18% | EF Hutton | → $10 | Reiterates | Buy → Buy |
05/26/2023 | 581.82% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
05/25/2023 | 468.18% | EF Hutton | → $10 | Reiterates | Buy → Buy |
05/25/2023 | 581.82% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
05/17/2023 | 922.73% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
05/11/2023 | 468.18% | EF Hutton | → $10 | Reiterates | Buy → Buy |
05/11/2023 | 581.82% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
03/16/2023 | 581.82% | HC Wainwright & Co. | $7 → $12 | Maintains | Buy |
02/21/2023 | 297.73% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
02/14/2023 | 468.18% | EF Hutton | → $10 | Maintains | Buy |
01/05/2023 | 468.18% | EF Hutton | → $10 | Initiates Coverage On | → Buy |
11/14/2022 | 13.64% | Piper Sandler | $6 → $2 | Maintains | Overweight |
10/25/2022 | 297.73% | HC Wainwright & Co. | $26 → $7 | Maintains | Buy |
06/03/2022 | 752.27% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
03/08/2021 | 1377.27% | BTIG | → $26 | Initiates Coverage On | → Buy |
09/18/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
07/23/2020 | 1377.27% | HC Wainwright & Co. | $15 → $26 | Maintains | Buy |
03/27/2020 | 752.27% | HC Wainwright & Co. | $25 → $15 | Maintains | Buy |
12/20/2019 | 1320.45% | HC Wainwright & Co. | $31 → $25 | Maintains | Buy |
12/10/2019 | 1604.55% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
11/20/2019 | 1661.36% | HC Wainwright & Co. | $18 → $31 | Reiterates | → Buy |
11/19/2019 | 1945.45% | Piper Sandler | $15 → $36 | Maintains | Overweight |
10/10/2019 | 922.73% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
05/13/2019 | 468.18% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
04/09/2019 | 695.45% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
07/21/2023 | 922.73% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
07/17/2023 | 922.73% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
07/10/2023 | 922.73% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
07/03/2023 | 922.73% | 康託·菲茨傑拉德 | $18→$18 | 重申 | 超重→超重 |
06/05/2023 | 581.82% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
06/05/2023 | 468.18% | EF Hutton | →$10 | 重申 | 購買→購買 |
2023年05月26日 | 468.18% | EF Hutton | →$10 | 重申 | 購買→購買 |
2023年05月26日 | 581.82% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
2023年05月25日 | 468.18% | EF Hutton | →$10 | 重申 | 購買→購買 |
2023年05月25日 | 581.82% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
2023年05月17日 | 922.73% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
2023年05月11日 | 468.18% | EF Hutton | →$10 | 重申 | 購買→購買 |
2023年05月11日 | 581.82% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
03/16/2023 | 581.82% | HC Wainwright公司 | $7→$12 | 維護 | 買 |
02/21/2023 | 297.73% | HC Wainwright公司 | →$7 | 重申 | →購買 |
02/14/2023 | 468.18% | EF Hutton | →$10 | 維護 | 買 |
01/05/2023 | 468.18% | EF Hutton | →$10 | 開始承保 | →購買 |
2022年11月14日 | 13.64% | 派珀·桑德勒 | $6→$2 | 維護 | 超重 |
2022年10月25日 | 297.73% | HC Wainwright公司 | $26→$7 | 維護 | 買 |
06/03/2022 | 752.27% | 羅斯資本 | →$15 | 開始承保 | →購買 |
03/08/2021 | 1377.27% | BTIG | →$26 | 開始承保 | →購買 |
09/18/2020 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
07/23/2020 | 1377.27% | HC Wainwright公司 | $15→$26 | 維護 | 買 |
03/27/2020 | 752.27% | HC Wainwright公司 | $25→$15 | 維護 | 買 |
2019年12月20日 | 1320.45% | HC Wainwright公司 | $31→$25 | 維護 | 買 |
2019年12月10日 | 1604.55% | 康託·菲茨傑拉德 | →$30 | 開始承保 | →超重 |
2019年11月20日 | 1661.36% | HC Wainwright公司 | $18→$31 | 重申 | →購買 |
2019年11月19日 | 1945.45% | 派珀·桑德勒 | $15→$36 | 維護 | 超重 |
2019年10月10日 | 922.73% | HC Wainwright公司 | →$18 | 開始承保 | →購買 |
2019年05月13日 | 468.18% | 派珀·桑德勒 | →$10 | 開始承保 | →超重 |
2019年09月04日 | 695.45% | 韋德布什 | →$14 | 開始承保 | →跑贏大盤 |
What is the target price for Aravive (ARAV)?
Aravive(ARAV)的目標價是多少?
The latest price target for Aravive (NASDAQ: ARAV) was reported by Cantor Fitzgerald on July 21, 2023. The analyst firm set a price target for $18.00 expecting ARAV to rise to within 12 months (a possible 922.73% upside). 19 analyst firms have reported ratings in the last year.
康託·菲茨傑拉德於2023年7月21日報道了Aravive(納斯達克代碼:ARIV)的最新目標價。這家分析公司將目標價定為18美元,預計ARAV值將在12個月內上漲(可能上漲922.73%)。去年有19家分析公司公佈了評級。
What is the most recent analyst rating for Aravive (ARAV)?
分析師對Aravive(ARAV)的最新評級是多少?
The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by Cantor Fitzgerald, and Aravive reiterated their overweight rating.
分析師對Aravive(納斯達克代碼:ARIV)的最新評級由康託·菲茨傑拉德提供,Aravive重申其增持評級。
When is the next analyst rating going to be posted or updated for Aravive (ARAV)?
Aravive(ARAV)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on July 21, 2023 so you should expect the next rating to be made available sometime around July 21, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Aravive的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Aravive的上一次評級是在2023年7月21日提交的,所以你應該預計下一次評級將在2024年7月21日左右提供。
Is the Analyst Rating Aravive (ARAV) correct?
分析師對Aravive(ARAV)的評級正確嗎?
While ratings are subjective and will change, the latest Aravive (ARAV) rating was a reiterated with a price target of $0.00 to $18.00. The current price Aravive (ARAV) is trading at is $1.76, which is within the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Aravive(ARAV)評級被重申,目標價在0.00美元至18.00美元之間。Aravive(ARAV)目前的交易價格為1.76美元,在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。